We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current GLABF market cap is 30.44M. The company's latest EPS is CAD -0.0810 and P/E is -5.06.
Year End January 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 219k | 0 |
Operating Income | -436k | -4.25M | -5.71M |
Net Income | -834k | -4.74M | -5.98M |
Year End January 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 2.53M | 1.42M | 1.88M |
Total Liabilities | 2.37M | 476k | 1.95M |
Total Equity | 160k | 944k | -72k |
Year End January 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | |
Operating | -320k | -3.87M | -4.51M |
Investing | 14k | 8k | -505k |
Financing | 1.19M | 4.14M | 3.94M |
Market Cap | 30.44M |
Price to Earnings Ratio | -5.06 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 372.73 |
Price to Book Ratio | -420.08 |
Dividend Yield | - |
Shares Outstanding | 73.77M |
Average Volume (1 week) | 300 |
Average Volume (1 Month) | 7.65k |
52 Week Change | -23.59% |
52 Week High | 0.6957 |
52 Week Low | 0.299 |
Spread (Intraday) | 0.2 (47.51%) |
Company Name | Gemina Laboratories Ltd (PK) |
Address |
10th floor, 595 howe street vancouver, british columbia |
Website | https://www.geminalabs.com |
Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions